Monitoring Metabolic Health in Psychiatric Patients on Antipsychotics
Author Information
Author(s): Mackin Paul, Bishop David R, Watkinson Helen MO
Primary Institution: Newcastle University
Hypothesis
How effective are monitoring practices for metabolic disease in patients treated with antipsychotic medications?
Conclusion
Patients treated with antipsychotics have a high prevalence of metabolic disease and poor monitoring practices, leading to worsening health outcomes.
Supporting Evidence
- A high prevalence of undiagnosed metabolic disease was found at baseline.
- Monitoring practices were poor, with 0% of individuals having their BMI recorded.
- Only 7% of patients were receiving lipid-lowering therapy despite high rates of dyslipidemia.
Takeaway
This study looked at how well doctors check the health of patients on antipsychotic medications. It found that many patients are not getting the health checks they need.
Methodology
A prospective cohort study with detailed assessments of metabolic status and monitoring practices in 106 psychiatric patients.
Potential Biases
Participants may not represent the general population of psychiatric patients, as those not in contact with services may have worse health.
Limitations
The study may not represent all psychiatric patients as participants were recruited from outpatient clinics and may be more health-conscious.
Participant Demographics
90 patients, 49% male, 51% female, 98% Caucasian, with various psychiatric diagnoses including bipolar disorder and schizophrenia.
Statistical Information
P-Value
p < 0.005 for BMI, p < 0.05 for waist circumference
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website